The manufacturer of ACWY Vax (meningococcal polysaccharide groups ACW135Y vaccine) has written to healthcare professionals advising that this product is being discontinued in the UK. It is expected that stocks will be exhausted by June 2014.
The letter notes that two alternative conjugate vaccines that contain the same A, C, W135 and Y strains are available but also notes that the licensed indications may differ. The brand names for these products are Menveo® and Nimenrix®.
Action: Clinicians who currently use ACWY Vax should be aware of this product being discontinued and make themselves familiar with the alternatives.
|« NICE Guidance - March 2014||SMC Update - April 2014 »|